Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIa Study of the Effects of a New Oral Formulation of Salmon Calcitonin in Human Osteoarthritis

NCT00376311 is registered in ClinicalTrials.gov with Université Catholique de Louvain as lead sponsor.

NCT NCT00376311
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00376311 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIa Study of the Effects of a New Oral Formulation of Salmon Calcitonin in Human Osteoarthritis
Lead sponsor
Université Catholique de Louvain
Phase
Phase 2
Overall status
Terminated
Start date
September 30, 2002
Completion date
May 31, 2004
Enrollment
54
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis